title: [Trends of prostate cancer: comparison between 1986-90 and 1991-95 at Asahi General Hospital].
abstract: Patients with prostate cancer treated during 1986-95 were divided into two groups: the first five years as early period and the recent five years as late period. Background factors, therapeutic modality and prognosis were compared between these two groups. The number of patients during the late period (245) was about 1.5 fold that during the early period (161). The average age for each stage are similar within the same period, and also similar between early and late periods. Almost the same ratios were noticed on stage distribution and on histological grade between early and late periods. Therefore, the increase in the number of patients in recent years was due mainly to expansion with the same proportion of background factors. Patients with T2 and T3 during the late period received more aggressive treatments with/without endocrine therapy. Subsequently these patients seemed to show better prognosis than the patients during the early period. No differences in survival of patients with metastosis was revealed between these two periods. Therefore, the outcome was not improved by recent endocrine therapy.
authors.affiliation: Department of Urology, Asahi General Hospital.
authors.forename: M
authors.initials: M
authors.lastname: Tanaka
authors.forename: S
authors.initials: S
authors.lastname: Murakami
authors.forename: N
authors.initials: N
authors.lastname: Suzuki
authors.forename: T
authors.initials: T
authors.lastname: Oikawa
authors.forename: H
authors.initials: H
authors.lastname: Kinsui
authors.forename: S
authors.initials: S
authors.lastname: Hamano
authors.forename: J
authors.initials: J
authors.lastname: Shimazaki
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008495:Medical Oncology / Q000639:trends; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D015996:Survival Rate
chemical_list: D000726:Androgen Antagonists; D004965:Estrogen Antagonists